On September 5th, 2023, a Miami jury found a medical clinic owner and pharmacist guilty of falsifying and fabricating clinical trial data.
We highlight the significance of pharmacists recognizing red flags indicating potential fraud, including patients unknowingly or involuntarily enrolled in clinical trials.
Beyond the broader impact on public trust, pharmacists could face specific repercussions, such as disciplinary actions from the State Board of Pharmacy. Moreover, clinic owners could be barred from participating in research activities.
Implementing robust internal controls and collaborating with law enforcement to identify and report suspected fraud are essential steps for pharmacists and clinic owners to safeguard themselves from legal ramifications.
#clinicaltrialfarud #fraudprevention #pharmacisttips #healthcareregulations #clinicaltrial #clinicalresearch #trialintegrity #pharmacycompliance #kulkarnilawfirm #klf #darshantalks #dt #recentrecap
Sign up for our newsletter- https://darshantalks.com/
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
LinkedIn: https://www.linkedin.com/in/darshankulkarni/
----
Disclaimers:
This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. Listening to this video or otherwise depending on discussions in this video do not, in any way, create an attorney attorney-client relationship
- Listen on:
- Spotify
- Apple
- Stitcher
- iHeart Radio